Pharmaceutical Research

Valuable Data + Competent Presentation = Good Science
pp. 957-957(1)
Author: Testa B.

Value of Pharmaceutical Sciences
pp. 958-966(9)
Author: Borchardt R.T.

Cmax/AUC, A Commentary
pp. 967-968(2)
Authors: Tozer T.N.; Hauck W.W.

Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice
pp. 969-975(7)
Authors: Carpenter J.F.; Pikal M.J.; Chang B.S.; Randolph T.W.

Cooperation in Pharmacy-Drug Wholesaler Relations
pp. 976-983(8)
Authors: Doucette W.R.; Wiederholt J.B.

Discrimination Between Rival Dosing Histories
pp. 984-991(8)
Authors: Jonsson E.N.; Wade J.R.; Almqvist G.; Karlsson M.O.

Liposome-Mediated Therapy of Intracranial Brain Tumors in a Rat Model
pp. 992-998(7)
Authors: Sharma U.S.; Sharma A.; Chau R.I.; Straubinger R.M.

Pharmacokinetic Analysis of Benzodiazepine Receptor Binding of [123I]Iomazenil in Human Brain
pp. 999-1003(5)
Authors: Ito K.; Momose T.; Kotaki H.; Kojima Y.; Yamamoto K.; Katashima M.; Sawada Y.; Sasaki Y.; Iga T.

Metabolism of Azetirelin, a New Thyrotropin-releasing Hormone (TRH) Analogue, by Intestinal Microorganisms
pp. 1004-1007(4)
Authors: Sasaki I.; Tamura T.; Shibakawa T.; Fujita T.; Murakami M.; Yamamoto A.; Muranishi S.

Hepatic Extraction of Hexarelin, a New Peptidic GH Secretagogue, in the Isolated Perfused Rat Liver
pp. 1008-1013(6)
Authors: Roumi M.; Marleau S.; Boghen M.; Nilsson M.; Du Souich P.; Ong H.

Comparison of the Disposition of Hepatically-Generated Morphine-3-glucuronide and Morphine-6-glucuronide in Isolated Perfused Liver from the Guinea Pig
pp. 1014-1018(5)
Authors: Milne R.W.; Jensen R.H.; Larsen C.; Evans A.M.; Nation R.L.

Comparison of CYP3A Activities in a Subclone of Caco-2 Cells (TC7) and Human Intestine
pp. 1019-1025(7)
Authors: Raeissi S.D.; Guo Z.; Dobson G.L.; Artursson P.; Hidalgo I.J.

Prodrug and Analog Approaches to Improving the Intestinal Absorption of a Cyclic Peptide, GPIIb/IIIa Receptor Antagonist
pp. 1026-1029(4)
Authors: Saitoh H.; Aungst B.J.

Mechanisms of Food Effects of Structurally Related Antiarrhythmic Drugs, Disopyramide and Bidisomide in the Rat
pp. 1030-1038(9)
Authors: Lee K-H.; Xu G-X.; Schoenhard G.L.; Cook C.S.

Consolidation Mechanisms of Pharmaceutical Solids: A Multi-Compression Cycle Approach
pp. 1039-1045(7)
Authors: Khossravi D.; Morehead W.T.

Determination of Extent of Formaldehyde-Induced Crosslinking in Hard Gelatin Capsules by Near-Infrared Spectrophotometry
pp. 1046-1050(5)
Authors: Gold T.B.; Buice Jr. R.G.; Lodder R.A.; Digenis G.A.

Circulatory Concentrations of Fibrinolytic Species During Thrombolytic Therapy Estimated by Stirred-Tank Reactor Analysis
pp. 1051-1057(7)
Authors: Tbliani V.V.; O'Rear E.A.

Effect of Vehicles and Penetration Enhancers on the In Vitro and In Vivo Percutaneous Absorption of Methotrexate and Edatrexate Through Hairless Mouse Skin
pp. 1058-1065(8)
Authors: Chatterjee D.J.; Li W.Y.; Koda R.T.

Simultaneous In Vivo Visualization and Localization of Solid Oral Dosage Forms in the Rat Gastrointestinal Tract by Magnetic Resonance Imaging (MRI)
pp. 1066-1072(7)
Authors: Christmann V.; Rosenberg J.; Seega J.; Lehr C-M.

Spreading and Retention of Vaginal Formulations in Post-Menopausal Women as Assessed by Gamma Scintigraphy
pp. 1073-1078(6)
Authors: Brown J.; Hooper G.; Kenyon C.J.; Haines S.; Burt J.; Humphries J.M.; Newman S.P.; Davis S.S.; Sparrow R.A.; Wilding I.R.

Studies on the Mechanism of Absorption of Depot Neuroleptics: Fluphenazine Decanoate in Sesame oil
pp. 1079-1084(6)
Authors: Luo J-P.; Hubbard J.W.; Midha K.K.

Carboxyl-directed Pegylation of Brain-derived Neurotrophic Factor Markedly Reduces Systemic Clearance with Minimal Loss of Biologic Activity
pp. 1085-1091(7)
Authors: Sakane T.; Pardridge W.M.

Evaluation of Genetic Stability of Recombinant Human Factor VIII by Peptide Mapping and On-line Mass Spectrometric Analysis
pp. 1092-1098(7)
Authors: Besman M.J.; Shiba D.

Cocaine Pharmacokinetics/ Pharmacodynamics in Awake Freely Moving Rats
pp. 1099-1102(4)
Authors: Hedaya M.A.; Pan W-J.